NewEdge Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $229K | Buy |
704
+703
| +70,300% | +$229K | ﹤0.01% | 2153 |
|
|
2025
Q1 | $270 | Sell |
1
-972
| -100% | -$262K | ﹤0.01% | 3778 |
|
|
2024
Q4 | $229K | Buy |
973
+972
| +97,200% | +$229K | ﹤0.01% | 2021 |
|
|
2024
Q3 | $275 | Sell |
1
-994
| -100% | -$273K | ﹤0.01% | 3662 |
|
|
2024
Q2 | $242K | Buy |
995
+977
| +5,428% | +$237K | ﹤0.01% | 1828 |
|
|
2024
Q1 | $2.69K | Buy |
18
+14
| +350% | +$2.09K | ﹤0.01% | 3314 |
|
|
2023
Q4 | $765 | Hold |
4
| – | – | ﹤0.01% | 3497 |
|
|
2023
Q3 | $708 | Hold |
4
| – | – | ﹤0.01% | 3215 |
|
|
2023
Q2 | $760 | Hold |
4
| – | – | ﹤0.01% | 3281 |
|
|
2023
Q1 | $801 | Sell |
4
-60
| -94% | -$12K | ﹤0.01% | 3187 |
|
|
2022
Q4 | $13.8K | Buy |
+64
| New | +$13.8K | ﹤0.01% | 2263 |
|